1 Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: patrick_wen@dfci.harvard.edu.
2 Global Drug Development, Oncology Development Unit, Novartis Pharmaceuticals, Basel, Switzerland.
3 Global Drug Development, Oncology Development Unit, Novartis Pharma, East Hanover, NJ, USA.
4 Phase I Clinical Trials Program, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.